Metabolomics Workbench : NIH Data Repository

Analysis	Metabolite Name	Measured Value	Units	CASE_CONTROL	Chemotherapy	Drug	Race	TIMEPOINT	Tamoxyfen	Taxane
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+CL)-	4793	Peak area	Case	N	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+CL)-	6412	Peak area	Control	N	Letrozole	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+CL)-	7795	Peak area	Case	Y	Letrozole	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+CL)-	7988	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+CL)-	7998	Peak area	Case	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+CL)-	9393	Peak area	Control	Y	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+CL)-	11308	Peak area	Case	N	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+CL)-	11794	Peak area	Case	Y	Exemestane	White	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+CL)-	12072	Peak area	Case	N	Letrozole	Black	3 Month	N	N
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+CL)-	12131	Peak area	Control	Y	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+CL)-	12338	Peak area	Case	N	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+CL)-	12911	Peak area	Case	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+CL)-	12999	Peak area	Control	Y	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+CL)-	13097	Peak area	Case	Y	Exemestane	Black	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+CL)-	13556	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+CL)-	13829	Peak area	Case	N	Exemestane	Black	Baseline	N	N
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+CL)-	13844	Peak area	Control	Y	Exemestane	White	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+CL)-	14342	Peak area	Case	N	Letrozole	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+CL)-	14465	Peak area	Control	Y	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+CL)-	14521	Peak area	Control	Y	Exemestane	White	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+CL)-	14584	Peak area	Case	Y	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+CL)-	14651	Peak area	Case	N	Letrozole	Black	Baseline	N	N
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+CL)-	14686	Peak area	Case	N	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+CL)-	14919	Peak area	Case	Y	Exemestane	Black	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+CL)-	15082	Peak area	Case	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+CL)-	15207	Peak area	Case	N	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+CL)-	15384	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+CL)-	15697	Peak area	Case	N	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+CL)-	15722	Peak area	Case	Y	Letrozole	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+CL)-	15823	Peak area	Control	N	Letrozole	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+CL)-	15838	Peak area	Case	Y	Exemestane	White	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+CL)-	15981	Peak area	Control	N	Exemestane	Black	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+CL)-	16090	Peak area	Case	Y	Letrozole	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+CL)-	16099	Peak area	Case	Y	Exemestane	White	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+CL)-	16528	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+CL)-	16802	Peak area	Case	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+CL)-	16869	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+CL)-	17484	Peak area	Control	Y	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+CL)-	17591	Peak area	Case	N	Letrozole	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+CL)-	18071	Peak area	Case	Y	Letrozole	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+CL)-	18324	Peak area	Case	N	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+CL)-	18372	Peak area	Control	N	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+CL)-	18670	Peak area	Control	Y	Exemestane	White	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+CL)-	19001	Peak area	Case	Y	Exemestane	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+CL)-	19089	Peak area	Control	N	Exemestane	Black	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+CL)-	19217	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+CL)-	20540	Peak area	Case	Y	Exemestane	White	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+CL)-	20619	Peak area	Case	N	Letrozole	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+CL)-	20713	Peak area	Control	Y	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+CL)-	20840	Peak area	Case	Y	Exemestane	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+CL)-	20898	Peak area	Control	N	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+CL)-	20920	Peak area	Case	N	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+CL)-	21025	Peak area	Case	Y	Exemestane	White	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+CL)-	21168	Peak area	Case	N	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+CL)-	21183	Peak area	Case	N	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+CL)-	21240	Peak area	Control	N	Letrozole	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+CL)-	21307	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+CL)-	21502	Peak area	Case	Y	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+CL)-	21525	Peak area	Case	Y	Letrozole	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+CL)-	21574	Peak area	Control	N	Letrozole	Black	3 Month	N	N
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+CL)-	21606	Peak area	Case	N	Exemestane	Black	3 Month	N	N
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+CL)-	21679	Peak area	Case	Y	Exemestane	White	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+CL)-	21743	Peak area	Case	Y	Letrozole	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+CL)-	21886	Peak area	Control	N	Letrozole	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+CL)-	21971	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+CL)-	22231	Peak area	Control	N	Letrozole	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+CL)-	22589	Peak area	Control	Y	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+CL)-	22791	Peak area	Case	Y	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+CL)-	22822	Peak area	Case	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+CL)-	23140	Peak area	Case	Y	Exemestane	White	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+CL)-	23326	Peak area	Control	Y	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+CL)-	23421	Peak area	Control	Y	Letrozole	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+CL)-	23442	Peak area	Control	N	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+CL)-	23601	Peak area	Case	N	Letrozole	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+CL)-	23650	Peak area	Control	N	Letrozole	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+CL)-	23733	Peak area	Case	Y	Exemestane	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+CL)-	24096	Peak area	Control	Y	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+CL)-	24401	Peak area	Case	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+CL)-	25022	Peak area	Case	Y	Exemestane	White	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+CL)-	25560	Peak area	Control	N	Letrozole	Black	Baseline	N	N
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+CL)-	25817	Peak area	Control	Y	Letrozole	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+CL)-	26243	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+CL)-	26294	Peak area	Control	Y	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+CL)-	26553	Peak area	Control	Y	Exemestane	White	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+CL)-	26610	Peak area	Control	N	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+CL)-	27405	Peak area	Case	N	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+CL)-	27737	Peak area	Control	N	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+CL)-	28196	Peak area	Control	Y	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+CL)-	28447	Peak area	Control	N	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+CL)-	28993	Peak area	Case	Y	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+CL)-	29197	Peak area	Control	Y	Letrozole	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+CL)-	29203	Peak area	Control	N	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+CL)-	29228	Peak area	Control	Y	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+CL)-	30752	Peak area	Case	Y	Exemestane	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+CL)-	32771	Peak area	Control	N	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+CL)-	34317	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+CL)-	35992	Peak area	Control	Y	Exemestane	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+CL)-	37256	Peak area	Control	Y	Letrozole	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+CL)-	39084	Peak area	Case	N	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+CL)-	44146	Peak area	Control	Y	Exemestane	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+HCOO)-	12579	Peak area	Case	N	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+HCOO)-	14732	Peak area	Control	N	Letrozole	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+HCOO)-	19495	Peak area	Case	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+HCOO)-	21043	Peak area	Case	Y	Letrozole	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+HCOO)-	22001	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+HCOO)-	24571	Peak area	Control	Y	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+HCOO)-	25055	Peak area	Case	N	Letrozole	Black	3 Month	N	N
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+HCOO)-	25507	Peak area	Case	N	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+HCOO)-	26223	Peak area	Case	N	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+HCOO)-	26796	Peak area	Case	Y	Exemestane	White	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+HCOO)-	28858	Peak area	Case	Y	Exemestane	Black	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+HCOO)-	29512	Peak area	Control	Y	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+HCOO)-	29903	Peak area	Case	N	Letrozole	Black	Baseline	N	N
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+HCOO)-	30344	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+HCOO)-	30424	Peak area	Case	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+HCOO)-	31215	Peak area	Case	N	Letrozole	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+HCOO)-	31268	Peak area	Control	Y	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+HCOO)-	32680	Peak area	Case	N	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+HCOO)-	32720	Peak area	Control	Y	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+HCOO)-	32949	Peak area	Case	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+HCOO)-	32952	Peak area	Control	Y	Exemestane	White	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+HCOO)-	32985	Peak area	Case	Y	Exemestane	White	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+HCOO)-	33513	Peak area	Case	N	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+HCOO)-	33522	Peak area	Case	Y	Letrozole	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+HCOO)-	33668	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+HCOO)-	33779	Peak area	Control	Y	Exemestane	White	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+HCOO)-	33908	Peak area	Case	Y	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+HCOO)-	33909	Peak area	Case	Y	Exemestane	White	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+HCOO)-	33984	Peak area	Case	N	Exemestane	Black	Baseline	N	N
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+HCOO)-	34031	Peak area	Case	Y	Exemestane	Black	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+HCOO)-	35441	Peak area	Case	Y	Letrozole	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+HCOO)-	35592	Peak area	Case	N	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+HCOO)-	35995	Peak area	Case	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+HCOO)-	37603	Peak area	Control	N	Exemestane	Black	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+HCOO)-	38619	Peak area	Control	N	Letrozole	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+HCOO)-	38687	Peak area	Case	N	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+HCOO)-	39001	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+HCOO)-	39282	Peak area	Control	N	Exemestane	Black	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+HCOO)-	40120	Peak area	Control	N	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+HCOO)-	40428	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+HCOO)-	40794	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+HCOO)-	42587	Peak area	Control	Y	Exemestane	White	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+HCOO)-	42912	Peak area	Control	Y	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+HCOO)-	43350	Peak area	Case	N	Letrozole	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+HCOO)-	43732	Peak area	Case	Y	Exemestane	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+HCOO)-	44048	Peak area	Case	Y	Letrozole	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+HCOO)-	44140	Peak area	Control	N	Letrozole	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+HCOO)-	44238	Peak area	Case	Y	Letrozole	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+HCOO)-	44486	Peak area	Case	N	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+HCOO)-	44971	Peak area	Case	Y	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+HCOO)-	45201	Peak area	Control	Y	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+HCOO)-	45356	Peak area	Case	Y	Exemestane	White	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+HCOO)-	46197	Peak area	Control	N	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+HCOO)-	46872	Peak area	Case	Y	Exemestane	White	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+HCOO)-	46992	Peak area	Control	N	Letrozole	Black	3 Month	N	N
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+HCOO)-	47092	Peak area	Case	Y	Exemestane	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+HCOO)-	47171	Peak area	Case	Y	Exemestane	White	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+HCOO)-	47807	Peak area	Case	N	Exemestane	Black	3 Month	N	N
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+HCOO)-	48027	Peak area	Control	N	Letrozole	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+HCOO)-	48059	Peak area	Case	N	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+HCOO)-	48548	Peak area	Case	Y	Letrozole	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+HCOO)-	48572	Peak area	Case	N	Letrozole	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+HCOO)-	49053	Peak area	Control	Y	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+HCOO)-	49307	Peak area	Control	N	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+HCOO)-	49405	Peak area	Case	Y	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+HCOO)-	49902	Peak area	Control	N	Letrozole	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+HCOO)-	50695	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+HCOO)-	50778	Peak area	Case	N	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+HCOO)-	51194	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+HCOO)-	52241	Peak area	Case	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+HCOO)-	52701	Peak area	Control	Y	Letrozole	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+HCOO)-	53001	Peak area	Case	Y	Exemestane	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+HCOO)-	53099	Peak area	Case	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+HCOO)-	53687	Peak area	Control	N	Letrozole	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+HCOO)-	54807	Peak area	Control	Y	Letrozole	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+HCOO)-	54874	Peak area	Control	Y	Exemestane	White	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+HCOO)-	55753	Peak area	Control	Y	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+HCOO)-	56184	Peak area	Control	Y	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+HCOO)-	56275	Peak area	Case	Y	Exemestane	White	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+HCOO)-	56491	Peak area	Control	Y	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+HCOO)-	57081	Peak area	Control	N	Letrozole	Black	Baseline	N	N
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+HCOO)-	57246	Peak area	Control	N	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+HCOO)-	57419	Peak area	Case	Y	Exemestane	White	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+HCOO)-	60736	Peak area	Case	N	Letrozole	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+HCOO)-	60885	Peak area	Control	Y	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+HCOO)-	61983	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+HCOO)-	62051	Peak area	Control	N	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+HCOO)-	63931	Peak area	Control	Y	Letrozole	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+HCOO)-	65019	Peak area	Case	N	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+HCOO)-	65249	Peak area	Case	Y	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+HCOO)-	67037	Peak area	Control	Y	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+HCOO)-	67752	Peak area	Control	N	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+HCOO)-	68815	Peak area	Control	N	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+HCOO)-	74216	Peak area	Case	Y	Exemestane	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+HCOO)-	74492	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+HCOO)-	80921	Peak area	Control	Y	Exemestane	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+HCOO)-	81645	Peak area	Control	N	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+HCOO)-	84799	Peak area	Case	N	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+HCOO)-	86666	Peak area	Control	Y	Letrozole	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	CORTISONE (CAS# 53-06-5); (M+HCOO)-	96912	Peak area	Control	Y	Exemestane	White	3 Month	Y	Y

Return to search page